摘要
背景:G9a是单原酶和组蛋白H3赖氨酸9,形式主要是异源复合物为G9a GLP双(G9a样蛋白),是一种在体内的功能性的组蛋白赖氨酸甲基化转移酶。越来越多的证据表明G9a催化组蛋白和非组蛋白的甲基化在不同的生物过程和人类疾病中起着至关重要的作用。 方法:在这项研究中,对G9a和抑制剂的生物学功能研究进展作一综述。 结果:我们综述G9a的生物学功能目前的知识,特别强调在涉及到人类疾病调节基因表达和细胞过程。开始从文章和专利列出了不同类别的G9A抑制剂,并重点探讨它们的发现,活跃情况和研究现状。 结论:我们强调了潜在的生物学功能和各种人类疾病的关键知识,同时综述发现G9A抑制剂的表征。然而,我们也提出了在研究G9a未来的机会的挑战,对于开发分子靶向药物G9a的漫长历程有着重要的贡献。
关键词: 组蛋白赖氨酸甲基化转移酶,组蛋白甲基化转移酶G9a,生物功能抑制剂,疾病,肿瘤靶点。
图形摘要
Current Cancer Drug Targets
Title:G9a - An Appealing Antineoplastic Target
Volume: 17 Issue: 6
关键词: 组蛋白赖氨酸甲基化转移酶,组蛋白甲基化转移酶G9a,生物功能抑制剂,疾病,肿瘤靶点。
摘要: Background: G9a is the primary enzyme for mono- and dimethylation at Lys 9 of histone H3 and forms predominantly the heteromeric complex as a G9a-GLP (G9a-like protein) that is a functional histone lysine methltransferase in vivo. Mounting evidence suggests that G9a catalyzes methylation of histone and nonhistone proteins, which plays a crucial role in diverse biological processes and human diseases.
Methods: In this study, the current knowledge on biological functions of G9a and inhibitors were summarized. Results: we review the current knowledge on biological functions of G9a, with particular emphasis on regulating gene expression and cell processes, and involvement in human diseases. We outline a perspective on various classes of G9a inhibitors to date from both articles and patents with an emphasis on their discovery, activity and the current research status. Conclusion: We highlight the key knowledge on potential biological functions and various human diseases. We also reviewed the discovery and characterization of the reported G9a inhibitors. However, we also propose the challenges and future opportunities in study of G9a. This review could make a crucial contribution to the long journey to develop drug-like molecules targeting G9a.Export Options
About this article
Cite this article as:
G9a - An Appealing Antineoplastic Target, Current Cancer Drug Targets 2017; 17 (6) . https://dx.doi.org/10.2174/1568009616666160512145303
DOI https://dx.doi.org/10.2174/1568009616666160512145303 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms
Current Cancer Drug Targets Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer
Anti-Cancer Agents in Medicinal Chemistry Cancer and Stem Cells
Current Cancer Therapy Reviews Serpin Regulation of Fibrinolytic System: Implications for Therapeutic Applications in Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Molecular Diagnostics of Fine Needle Aspiration for the Presurgical Screening of Thyroid Nodules
Current Genomics Arginyl Aminopeptidase-Like 1 (RNPEPL1) Is an Alternatively Processed Aminopeptidase with Specificity for Methionine, Glutamine, and Citrulline Residues
Protein & Peptide Letters Synthesis and Anti Cervical Cancer Activity of Novel 5H-Thiochromeno [4,3-d]pyrimidines
Letters in Organic Chemistry The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Current Topics in Medicinal Chemistry Hypoxia-Inducible Factor-1α Contributes to Brain Edema after Stroke by Regulating Aquaporins and Glycerol Distribution in Brain
Current Neurovascular Research Podocytes as Target of Vitamin D
Current Diabetes Reviews The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials
Current Cancer Therapy Reviews Evolution of Molecular Targets in Melanoma Treatment
Current Pharmaceutical Design Apis mellifera Proteomics: Where Will the Future Bee?
Current Proteomics Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
Recent Patents on Anti-Cancer Drug Discovery Molecular Modeling of Sulfonylmorpholinopyrimidines as the Ataxia Telangiectasis Mutated and RAD3-related (ATR) Protein Kinase Inhibitors by Computational Explorations
Letters in Drug Design & Discovery Bovine Serum Albumin Significantly Improves the DPPH Free Radical Scavenging Potential of Dietary Polyphenols and Gallic Acids
Anti-Cancer Agents in Medicinal Chemistry Prospects of Applying Enhanced Semi-Empirical QM Methods for 2101 Virtual Drug Design
Current Medicinal Chemistry Pre-Clinical and Clinical Aspects of Peptide-based Vaccine Against Human Solid Tumors
Recent Patents on Biotechnology Evaluating the Effect of Integra Seeded with Adipose Tissue-Derived Stem Cells or Fibroblasts in Wound Healing
Current Drug Delivery A Review of Density Functional Theory Quantum Mechanics as Applied to Pharmaceutically Relevant Systems
Current Computer-Aided Drug Design